Skip to main content

Table 2 Overview of adverse events

From: Safety of a fixed-dose combination of artesunate and amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in real-life conditions of use in Côte d’Ivoire

  Number of adverse events Number of episodes Incidence
Any adverse event 2545 1978 13.0% [12.5%; 13.6%]
Serious adverse events 105 100 0.7% [0.5%; 0.8%]
Severe adverse events 154 126 0.8% [0.7%; 1.0%]
Adverse events of special interest 3 3 <0.1%
Fatal serious adverse events 24 22 0.2% [0.1%; 0.2%]
Potentially ASAQ-related adverse events 929 837 5.5% [5.2%; 5.9%]
Adverse events requiring corrective treatment 157 105 0.7% [0.6%; 0.8%]